B
NPTN

Bailard’s NEOPHOTONICS CORP NPTN Stock Holding History

Bailard’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,201
Closed -$135K – 631
2020
Q2 		$135K Sell
15,201
-300
-2% -$2.59K 0.01% 470
2020
Q1 		$112K Buy
+15,501
New +$115K 0.01% 431
2019
Q4 		– Sell
-17,395
Closed -$106K – 623
2019
Q3 		$106K Buy
+17,395
New +$97.8K 0.01% 517

Other funds holding NPTN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Bailard's NPTN Position: Q3 2020 in Review

Bailard sold out of NEOPHOTONICS CORP (NPTN) in Q3 2020, closing a stake of 15,201 shares — an estimated $135K sold.

Bailard first reported a position in NPTN in Q3 2019 and held it in 3 quarters. The position peaked at $135K in Q2 2020. 140 funds tracked by Wall St. Rank hold NPTN as of Q3 2020.

  • Bailard reported no remaining NEOPHOTONICS CORP position as of Q3 2020 after selling out during the quarter.
  • Bailard sold 15,201 NEOPHOTONICS CORP shares in Q3 2020, an estimated $135K.
  • Bailard first reported a position in NEOPHOTONICS CORP in Q3 2019 and held it in 3 quarters.
  • Bailard's NEOPHOTONICS CORP position peaked at $135K in Q2 2020.
  • 140 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2020.

Based on Bailard's 13F filing for Q3 2020, filed 10 Nov 2020.